The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review.
J Intern Med
; 289(4): 450-462, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1102058
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic affecting all levels of health systems. This includes the care of patients with noncommunicable diseases (NCDs) who bear a disproportionate burden of both COVID-19 itself and the public health measures enacted to combat it. In this review, we summarize major COVID-19-related considerations for NCD patients and their care providers, focusing on cardiovascular, pulmonary, renal, haematologic, oncologic, traumatic, obstetric/gynaecologic, operative, psychiatric, rheumatologic/immunologic, neurologic, gastrointestinal, ophthalmologic and endocrine disorders. Additionally, we offer a general framework for categorizing the pandemic's disruptions by disease-specific factors, direct health system factors and indirect health system factors. We also provide references to major NCD medical specialty professional society statements and guidelines on COVID-19. COVID-19 and its control policies have already resulted in major disruptions to the screening, treatment and surveillance of NCD patients. In addition, it differentially impacts those with pre-existing NCDs and may lead to de novo NCD sequelae. Likely, there will be long-term effects from this pandemic that will continue to affect practitioners and patients in this field for years to come.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Manejo de Atención al Paciente
/
Control de Enfermedades Transmisibles
/
Enfermedades no Transmisibles
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Estudio observacional
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
J Intern Med
Asunto de la revista:
Medicina Interna
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Joim.13184
Similares
MEDLINE
...
LILACS
LIS